| The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors SB Willingham, JP Volkmer, AJ Gentles, D Sahoo, P Dalerba, SS Mitra, ... Proceedings of the National Academy of Sciences 109 (17), 6662-6667, 2012 | 1713 | 2012 |
| Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma MP Chao, AA Alizadeh, C Tang, JH Myklebust, B Varghese, S Gill, M Jan, ... Cell 142 (5), 699-713, 2010 | 1207 | 2010 |
| Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer: long-term results of a multi-institutional … DR Gomez, C Tang, J Zhang, GR Blumenschein Jr, M Hernandez, JJ Lee, ... Journal of Clinical Oncology 37 (18), 1558-1565, 2019 | 1134 | 2019 |
| Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic … DR Gomez, GR Blumenschein, JJ Lee, M Hernandez, R Ye, DR Camidge, ... The lancet oncology 17 (12), 1672-1682, 2016 | 1087 | 2016 |
| State-of-the-art strategies for targeting the DNA damage response in cancer PG Pilié, C Tang, GB Mills, TA Yap Nature reviews Clinical oncology 16 (2), 81-104, 2019 | 991 | 2019 |
| Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies AS Lee, C Tang, MS Rao, IL Weissman, JC Wu Nature medicine 19 (8), 998-1004, 2013 | 769 | 2013 |
| Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia MP Chao, AA Alizadeh, C Tang, M Jan, R Weissman-Tsukamoto, F Zhao, ... Cancer research 71 (4), 1374-1384, 2011 | 466 | 2011 |
| An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells C Tang, AS Lee, JP Volkmer, D Sahoo, D Nag, AR Mosley, MA Inlay, ... Nature biotechnology 29 (9), 829-834, 2011 | 449 | 2011 |
| Three differentiation states risk-stratify bladder cancer into distinct subtypes JP Volkmer, D Sahoo, RK Chin, PL Ho, C Tang, AV Kurtova, ... Proceedings of the National Academy of Sciences 109 (6), 2078-2083, 2012 | 383 | 2012 |
| Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes C Tang, Z Liao, D Gomez, L Levy, Y Zhuang, RA Gebremichael, DS Hong, ... International Journal of Radiation Oncology* Biology* Physics 89 (5), 1084-1091, 2014 | 345 | 2014 |
| Combining radiation and immunotherapy: a new systemic therapy for solid tumors? C Tang, X Wang, H Soh, S Seyedin, MA Cortez, S Krishnan, E Massarelli, ... Cancer immunology research 2 (9), 831-838, 2014 | 332 | 2014 |
| Ipilimumab with stereotactic ablative radiation therapy: phase I results and immunologic correlates from peripheral T cells C Tang, JW Welsh, P De Groot, E Massarelli, JY Chang, KR Hess, S Basu, ... Clinical Cancer Research 23 (6), 1388-1396, 2017 | 311 | 2017 |
| Effects of cell number on teratoma formation by human embryonic stem cells AS Lee, C Tang, F Cao, X Xie, K van der Bogt, A Hwang, AJ Connolly, ... Cell cycle 8 (16), 2608-2612, 2009 | 257 | 2009 |
| Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy MP Chao, C Tang, RK Pachynski, R Chin, R Majeti, IL Weissman Blood, The Journal of the American Society of Hematology 118 (18), 4890-4901, 2011 | 236 | 2011 |
| Suppression of type I IFN signaling in tumors mediates resistance to anti-PD-1 treatment that can be overcome by radiotherapy X Wang, JE Schoenhals, A Li, DR Valdecanas, H Ye, F Zang, C Tang, ... Cancer research 77 (4), 839-850, 2017 | 233 | 2017 |
| Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial J Welsh, H Menon, D Chen, V Verma, C Tang, M Altan, K Hess, ... Journal for immunotherapy of cancer 8 (2), 2020 | 212 | 2020 |
| Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors AA Chaudhuri, C Tang, MS Binkley, M Jin, JF Wynne, R von Eyben, ... Lung cancer 89 (1), 50-56, 2015 | 185 | 2015 |
| Design and synthesis of biomimetic hydrogel scaffolds with controlled organization of cyclic RGD peptides J Zhu, C Tang, K Kottke-Marchant, RE Marchant Bioconjugate chemistry 20 (2), 333-339, 2009 | 157 | 2009 |
| Development of an immune-pathology informed radiomics model for non-small cell lung cancer C Tang, B Hobbs, A Amer, X Li, C Behrens, JR Canales, EP Cuentas, ... Scientific reports 8 (1), 1922, 2018 | 146 | 2018 |
| Locally applied vascular endothelial growth factor A increases the osteogenic healing capacity of human adipose-derived stem cells by promoting osteogenic and endothelial … B Behr, C Tang, G Germann, MT Longaker, N Quarto Stem cells 29 (2), 286-296, 2011 | 141 | 2011 |
Ken HessProfessor, Biostatistics, UT MD Anderson Cancer CenterVerified email at mdanderson.org
